| Ident. | Authors (with country if any) | Title |
|---|
| 000141 (2014) |
Mathieu Verdurand [Australie, France] ; Victoria S. Dalton [Australie, Irlande (pays)] ; VU NGUYEN [Australie] ; Marie-Claude Gregoire [Australie] ; David Zahra [Australie] ; Naomi Wyatt [Australie] ; Leena Burgess [Australie] ; Ivan Greguric [Australie] ; Katerina Zavitsanou [Australie] | Prenatal poly I:C age-dependently alters cannabinoid type 1 receptors in offspring: A longitudinal small animal PET study using [18F]MK-9470 |
| 000332 (2014) |
Gilles Lambert [France, Australie] ; Francine Petrides [Australie] ; Mathias Chatelais [France] ; Dirk J. Blom [Afrique du Sud] ; Benjamin Choque [Australie] ; Fatiha Tabet [Australie] ; Gida Wong [Australie] ; Kerry-Anne Rye [Australie] ; Amanda J. Hooper [Australie] ; John R. Burnett [Australie] ; Philip J. Barter [Australie] ; A. David Marais [Afrique du Sud] | Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects |
| 000429 (2014) |
B. Escudier [France] ; M. D. Michaelson [États-Unis] ; R. J. Motzer [États-Unis] ; T. E. Hutson [États-Unis] ; J. I. Clark [États-Unis] ; H. Y. Lim [Corée du Sud] ; E. Porfiri [Royaume-Uni] ; P. Zalewski [Canada] ; G. Kannourakis [Australie] ; M. Staehler [Allemagne] ; J. Tarazi [États-Unis] ; B. Rosbrook [États-Unis] ; L. Cisar [États-Unis] ; S. Hariharan [États-Unis] ; S. Kim [États-Unis] ; B. I. Rini [États-Unis] | Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial |
| 000461 (2014) |
Marc Humbert [France] ; Edmund M. T. Lau [France, Australie] ; David Montani [France] ; Xavier Jaïs [France] ; Oliver Sitbon [France] ; Gérald Simonneau [France] | Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension |
| 001174 (2012) |
Philippe A. Cassier [France] ; Hans Gelderblom [Pays-Bas] ; Silvia Stacchiotti [Italie] ; David Thomas [Australie] ; Robert G. Maki [États-Unis] ; Judith R. Kroep [Pays-Bas] ; Winette T. Van Der Graaf [Pays-Bas] ; Antoine Italiano [France] ; Beatrice Seddon [Royaume-Uni] ; Julien Domont [France] ; Emanuelle Bompas [France] ; Andrew J. Wagner [États-Unis] ; Jean-Yves Blay [France] | Efficacy of Imatinib Mesylate for the Treatment of Locally Advanced and/or Metastatic Tenosynovial Giant Cell Tumor/ Pigmented Villonodular Synovitis |
| 001354 (2012) |
Kesia Palma-Rigo [Australie, France] ; Jaspreet K. Bassi [Australie] ; Thu-Phuc Nguyen-Huu [Australie] ; Kristy L. Jackson [Australie] ; Pamela J. Davern [Australie] ; Daian Chen [Australie] ; Jean-Luc Elghozi [France] ; Walter G. Thomas [Australie] ; Andrew M. Allen [Australie] ; Geoffrey A. Head [Australie] | Angiotensin 1A receptors transfected into caudal ventrolateral medulla inhibit baroreflex gain and stress responses |
| 001469 (2011) |
Benjamin Blacklow [Australie] ; Rachelle Kornhauser [Australie] ; Peter G. Hains [Australie] ; Richard Loiacono [Australie] ; Pierre Escoubas [France] ; Andis Graudins [Australie] ; Graham M. Nicholson [Australie] | α-Elapitoxin-Aa2a, a long-chain snake α-neurotoxin with potent actions on muscle (α-1)2βγδ nicotinic receptors, lacks the classical high affinity for neuronal α7 nicotinic receptors |
| 001737 (2011) |
Alberto S. Pappo [États-Unis] ; Shreyaskumar R. Patel [États-Unis] ; John Crowley [États-Unis] ; Denise K. Reinke [États-Unis] ; Klaus-Peter Kuenkele [Allemagne] ; Sant P. Chawla [États-Unis] ; Guy C. Toner [Australie] ; Robert G. Maki [États-Unis] ; Paul A. Meyers [États-Unis] ; Rashmi Chugh [États-Unis] ; Kristen N. Ganjoo [États-Unis] ; Scott M. Schuetze [États-Unis] ; Heribert Juergens [Allemagne] ; Michael G. Leahy [Royaume-Uni] ; Birgit Geoerger [France] ; Robert S. Benjamin [États-Unis] ; Lee J. Helman [États-Unis] ; Laurence H. Baker [États-Unis] | R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study |
| 001D07 (2011) |
Richard C. Becker [États-Unis] ; Jean Pierre Bassand [France] ; Andrzej Budaj [Pologne] ; Daniel M. Wojdyla [États-Unis] ; Stefan K. James [Suède] ; Jan H. Corner [Pays-Bas] ; John French [Australie] ; Claes Held [Suède] ; Jay Horrow [États-Unis] ; Steen Husted [Danemark] ; Jose Lopez-Sendon [Espagne] ; Riitta Lassila [Finlande] ; Kenneth W. Mahaffey [États-Unis] ; Robert F. Storey [Royaume-Uni] ; Robert A. Harrington [États-Unis] ; Lars Wallentin [Suède] | Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial |
| 002615 (2010) |
A. Koïtka [Australie] ; Z. Cao [Australie] ; P. Koh [Australie] ; A. M. D. Watson [Australie] ; K. C. Sourris [Australie] ; L. Loufrani [France] ; A. Soro-Paavonen [Australie] ; T. Walther [Royaume-Uni] ; K. J. Woollard [Australie] ; K. A. M. Jandeleit-Dahm [Australie] ; M. E. Cooper [Australie] ; T. J. Allen [Australie] | Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes |
| 002776 (2009) |
M. Matsuyama [Japon, France] ; K. Funao [Japon] ; J. Chargui [France] ; J.-L. Touraine [France] ; T. Nakatani [Japon] ; R. Yoshimura [Japon] | The Role of Cysteinyl-LT1 Receptor (CysLT1R) in Renal Ischemia-Reperfusion Injury |
| 002945 (2009) |
J. L. Dickinson [Australie] ; D. I. Perera [Australie] ; A. F. Van Der Mei [Australie] ; A.-L. Ponsonby [Australie] ; A. M. Polanowski [Australie] ; R. J. Thomson [Australie] ; B. V. Taylor [Australie] ; J. D. Mckay [France] ; J. Stankovich [Australie] ; T. Dwyer [Australie] | Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction |
| 003221 (2008) |
Billy C. Chieng [Australie] ; David J. Lee [Australie] ; Yan P. Du [Australie] ; Peregrine B. Osborne [Australie] ; Macdonald J. Christie [Australie] ; Dominique Massotte [France] | Functional coupling of μ-receptor-Gαi-tethered proteins in AtT20 cells |
| 003291 (2008) |
Laurent Besret [France] ; Frédéric Dolle [France] ; Anne-Sophie Herard [France] ; Martine Guillermier [France] ; Stéphane Demphel [France] ; Francoise Hinnen [France] ; Christine Coulon [France] ; Michèle Ottaviani [France] ; Michel Bottlaender [France] ; Philippe Hantraye [France] ; Michael Kassiou [Australie] | Dopamine D1 Receptor Imaging in the Rodent and Primate Brain Using the Isoquinoline (+)-[11C]A-69024 and Positron Emission Tomography |
| 003763 (2007) |
Timothy I. Webb [Australie] ; Joseph W. Lynch [Australie] | Molecular pharmacology of the glycine receptor chloride channel |
| 003902 (2007) |
A. J. Lawrence [Australie] ; A. Newman-Tancredi [Australie] ; M-B Assie [Australie] ; J-C Martel [Australie] ; C. Cosi [France] ; L. Bruins Slot [France] ; C. Palmier [France] ; I. Rauly-Lestienne [France] ; F. Colpaert [France] ; B. Vacher [France] ; D. Cussac [France] | F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties: (I) in vitro receptor affinity and efficacy profile |
| 003A84 (2007) |
Elodie Chabrol [France] ; Isabelle Gourfinkel An [France] ; Ingrid E. Scheffer [Australie] ; Fabienne Picard [Suisse] ; Philippe Couarch [France] ; Samuel F. Berkovic [Australie] ; Jacinta M. Mcmahon [Australie] ; Nandita Bajaj [Népal] ; Luisa Mota-Vieira [Portugal] ; Rui Mota [Portugal] ; Oriane Trouillard [France] ; Christel Depienne [France] ; Michel Baulac [France] ; Eric Leguern [France] ; Stephanie Baulac [France] | Absence of mutations in the LGL1 receptor ADAM22 gene in autosomal dominant lateral temporal epilepsy |
| 003B87 (2006) |
Mark L. Kahn [États-Unis, Australie, France] ; Pierre Mangin ; Cindy L. Yap ; Christelle Nonne ; Sharelle A. Sturgeon ; Isaac Goncalves ; YUPING YUAN ; Simone M. Schoenwaelder ; Christine E. Wright ; Francois Lanza ; Shaun P. Jackson | Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRγ deficiency. Commentary |
| 004009 (2006) |
J. L. Short [Australie] ; C. Ledent [Belgique] ; E. Borrelli [France] ; J. Drago [Australie] ; A. J. Lawrence [Australie] | Genetic interdependence of adenosine and dopamine receptors : Evidence from receptor knockout mice |
| 004346 (2005) |
John R. Teerlink [États-Unis] ; John J. V. Mcmurray [Royaume-Uni] ; Robert C. Bourge [États-Unis] ; John G. F. Cleland [Royaume-Uni] ; Gadi Cotter [États-Unis] ; Guillaume Jondeau [France] ; Henry Krum [Australie] ; Marco Metra [Italie] ; Christopher M. O'Connor [États-Unis] ; John D. Parker [Canada] ; Guillermo Torre-Amione [États-Unis] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Aline Frey [Suisse] ; Maurizio Rainisio [Suisse] ; Isaac Kobrin [Suisse] | Tezosentan in patients with acute heart failure : Design of the value of endothelin receptor inhibition with tezosentan in acute heart failure study (VERITAS) |
| 004432 (2005) |
Laurence Dufourny [États-Unis, France] ; Alain Caraty [France] ; Iain J. Clarke [Australie] ; Jane E. Robinson [Royaume-Uni] ; Donal C. Skinner [États-Unis] | Progesterone-receptive β-endorphin and dynorphin b neurons in the arcuate nucleus project to regions of high gonadotropin-releasing hormone neuron density in the ovine preoptic area : A retrograde labeling study |
